Modified carbapenem antibiotics with improved activity against kpc carbapenemase-producing enterobacterales
AssigneeSouthern Methodist University
InventorsJohn D. Buynak, Taariq Hassan, Pojun Quan
Life of this patent
Estimating the term…
Loading patent…
AssigneeSouthern Methodist University
InventorsJohn D. Buynak, Taariq Hassan, Pojun Quan
Estimating the term…
Provided herein are the design, preparation, evaluation, and use of structurally modified carbapenem antibiotics with improved activity, relative to current commercially available carbapenem antibiotics, against infections involving multidrug-resistant, carbapenemase-producing Enterobacterales strains. In particular, the new carbapenem antibiotics are demonstrated to produce improved activity, relative to current commercial carbapenem antibiotics, against bacterial strains producing a KPC carbapenemase. This invention includes their use as standalone antibiotics, as well as synergistic mixtures of the structurally modified carbapenems with carbapenemase inhibitors as well as synergistic mixtures of the newly modified carbapenems with other carbapenem antibiotics.
A compound of Formula I, or a pharmaceutically acceptable salt or ester thereof:
A method of making the compound of Formula I, comprising:
A composition comprising:
A method of treating a bacterial infection comprising:
Dependencies are inferred from the claim text.